首页> 外文期刊>Cancer research: The official organ of the American Association for Cancer Research, Inc >Heme-oxygenase-1 Production by Intestinal CX3CR1(+) Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis
【24h】

Heme-oxygenase-1 Production by Intestinal CX3CR1(+) Macrophages Helps to Resolve Inflammation and Prevents Carcinogenesis

机译:血红素氧酶-1通过肠CX3CR1(+)巨噬细胞产生有助于解决炎症并防止致癌物质

获取原文
获取原文并翻译 | 示例
           

摘要

CX3CR1(+) macrophages in the intestinal lamina propria contribute to gut homeostasis through the immunomodulatory interleukin IL10, but there is little knowledge on how these cells or the CX3CR1 receptor may affect colorectal carcinogenesis. In this study, we show that CX3CR1-deficient mice fail to resolve gut inflammation despite high production of IL10 and have increased colitis and adenomatous polyps in chemical and genetic models of colon carcinogenesis. Mechanistically, CX3CL1-mediated engagement of the CX3CR1 receptor induced upregulation of heme-oxygenase-1 (HMOX-1), an antioxidant and anti-inflammatory enzyme. CX3CR1-deficient mice exhibited significantly lower expression of HMOX-1 in their adenomatous colon tissues. Combining LPS and CX3CL1 displayed a strong synergistic effect in vitro, but HMOX-1 levels were significantly lower in KO macrophages. Cohousing of wild-type and CX3CR1-(/-) mice during the AOM/DSS treatment attenuated disease severity in CX3CR1-(/-) mice, indicating the importance of the microbiome, but did not fully reinstate HMOX-1 levels and did not abolish polyp formation. In contrast, pharmacologic induction of HMOX-1 in vivo by cobalt protoporphyrin-IX treatment eradicated intestinal inflammation and fully protected KO mice from carcinogenesis. Taken together, our results establish an essential role for the receptor CX3CR1 in gut macrophages in resolving inflammation in the intestine, where it helps protects against colitis-associated cancer by regulating HMOX-1 expression. (C)2017 AACR.
机译:CX3CR1(+)肠道丙蛋白巨噬细胞通过免疫调节性白细胞介素IL10有助于肠道稳态,但几乎没有了解这些细胞或CX3CR1受体可能影响结肠直肠癌的知识。在这项研究中,尽管高产IL10,CX3Cr1缺陷小鼠未能解决肠炎症,并且在结肠癌的化学和遗传模型中具有增加的结肠炎和腺瘤性息肉。机械上,CX3Cl1介导的CX3CR1受体诱导血红素 - 氧酶-1(HMOX-1)的上调,抗氧化剂和抗炎酶的接合。 CX3CR1缺陷小鼠在其腺瘤结肠组织中表现出HMOX-1的显着降低。结合LPS和CX3CL1在体外显示出强烈的协同效果,但KO巨噬细胞的HMOX-1水平显着降低。在AOM / DSS治疗期间伴有野生型和CX3CR1 - (/ - )小鼠的舒张减弱CX3CR1 - (/ - )小鼠的疾病严重程度,表明微生物组的重要性,但没有完全恢复HMOX-1水平并且没有废除息肉形成。相比之下,通过钴原子霉素-1x治疗的体内HMOX-1的药理诱导消除肠炎和来自致癌作用的完全受保护的Ko小鼠。我们的结果在一起,对肠道巨噬细胞的受体CX3CR1建立了基本作用,在肠道中解析炎症,在那里它有助于通过调节HMOX-1表达来保护结肠炎相关的癌症。 (c)2017年AACR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号